PTEN loss confers resistance to anti–PD-1 therapy in non–small cell lung cancer by increasing tumor infiltration of regulatory T cells

F Exposito, M Redrado, M Houry, K Hastings… - Cancer Research, 2023 - AACR
Immunotherapy resistance in non–small cell lung cancer (NSCLC) may be mediated by an
immunosuppressive microenvironment, which can be shaped by the mutational landscape …
被引用次数：7 相关文章

PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells.

F Exposito, M Redrado, M Houry, K Hastings… - Cancer …, 2023 - europepmc.org
Immunotherapy resistance in non-small cell lung cancer (NSCLC) may be mediated by an
immunosuppressive microenvironment, which can be shaped by the mutational landscape …

PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

F Exposito, M Redrado, M Houry… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Immunotherapy resistance in non-small cell lung cancer (NSCLC) may be mediated by an
immunosuppressive microenvironment, which can be shaped by the mutational landscape …

PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

F Exposito, M Redrado, M Houry, K Hastings… - Cancer Research, 2023 - AACR
Immunotherapy resistance in non–small cell lung cancer (NSCLC) may be mediated by an
immunosuppressive microenvironment, which can be shaped by the mutational landscape …

[引用][C] PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

F Exposito, M Redrado, M Houry… - Cancer …, 2023 - produccioncientifica.ucm.es